
MedCath Corp was founded in 1985 by a group of cardiologists who wanted to create a company that would provide high-quality cardiovascular services to patients.
The company started by acquiring a number of hospitals and cardiovascular centers in the southeastern United States.
MedCath Corp went public in 1995, listing its shares on the NASDAQ stock exchange.
The company continued to expand its operations, acquiring several more hospitals and medical facilities in the region.
Company Restructuring
MedCath Corp. underwent significant company restructuring in the early 2000s, which had a lasting impact on the company's operations.
The restructuring involved the sale of MedCath's cardiac catheterization laboratory (Cath Lab) business to Fresenius Medical Care, a German-based healthcare company. This move marked a shift in MedCath's focus towards providing hospital-based cardiovascular services.
The restructuring efforts also led to the elimination of 300 jobs, which was a significant reduction of MedCath's workforce at the time.
If this caught your attention, see: Debt Restructuring in Sri Lanka
Executives' Termination Agreements
In MedCath, the CEO Edwin French is stepping down and will be replaced by current CFO Art Parker, who will take over as CEO on September 23.
Art Parker is taking on a new role, and Lora Ramsey, the current Controller, will step into the CFO spot vacated by Parker.
The change in leadership at MedCath will take effect on September 23, marking the end of French's tenure as CEO and board member.
Suggestion: French Polynesian Franc
Assess Management Team Compensation
Assessing a company's management team compensation can be a complex task, but it's essential to understand how they're paid to evaluate the company's financial trajectory.
Medcath Corp's management team compensation can be found in their Annual Proxy, which outlines their salaries, bonuses, and perks.
To assess their compensation, look for the section on Salaries, Bonuses, Perks in the Annual Proxy.
Here are some key points to consider:
By evaluating Medcath Corp's management team compensation, you can gain insight into their financial trajectory and make informed decisions about the company's restructuring efforts.
Asset Sales and Acquisitions
MedCath has a history of selling its hospital assets, with the most recent sale being its last North Carolina hospital asset, Coastal Carolina Heart, which was sold to New Hanover Regional Medical Center for $5 million.
MedCath sold its North Carolina-based assets related to the operation of cardiac catheterization laboratories for $25 million to DLP Healthcare, retaining working capital and assets outside of North Carolina.
The company has also sold its stake in several hospitals across different states, including Texas, Arkansas, and New Mexico, for a total of $192 million.
A unique perspective: Cost of Goods Sold
Facility Sale in Texas
MedCath sold its stake in a Texas hospital, leaving the company with just one facility left in its portfolio.
The hospital, Harlingen Medical Center, is a 112-bed, acute care facility.
The transaction closed on Wednesday, with Prime Healthcare Services, a California hospital operator, purchasing MedCath's minority ownership.
MedCath's remaining asset is still unclear, but it's evident that the company is actively selling off its assets.
For more insights, see: Lean Facility Management
DLP Healthcare Acquisition Completed
MedCath Completes Sale of MedCath Partners' Operations to DLP Healthcare.
The transaction valued the assets acquired at $25.0 million. This sale involved the transfer of certain North Carolina-based assets related to the operation of cardiac catheterization laboratories in North Carolina.
MedCath will retain working capital related to the assets sold and assets related to cath labs leased to two health care systems outside of North Carolina as well as its minority ownership in one North Carolina joint venture.
MedCath anticipates that it will receive approximately $16.0 million from the transaction, after collection of related retained accounts receivable and payment of known liabilities, closing costs, and taxes.
Recommended read: What Car Companies Are Offering 0 Financing
Asset in North Carolina Fails

MedCath sold its last remaining piece in North Carolina for $5 million. This sale was a significant move for the company, marking a major shift in its hospital network.
The asset sold was Coastal Carolina Heart, which provides catheterization laboratory management services. This type of service is crucial for hospitals, as it involves managing and operating catheterization labs.
New Hanover Regional Medical Center in Wilmington, North Carolina, purchased MedCath's ownership stake and management agreement in Coastal Carolina Heart. This acquisition is a significant move for the medical center, expanding its services and capabilities.
The sale of this asset is a clear example of a company divesting itself of non-core assets to focus on more strategic goals.
You might like: Pokemon Go Sold to Scopely
Financial Performance
MedCath Corp. has shown a significant improvement in its financial performance. The company made a profit of $37 million in the fiscal first quarter.
This profit is a notable change from previous quarters, and it's likely due to the successful sale of a Texas hospital for $78.5 million. MedCath is looking to sell other hospitals as well.
The company's financial trajectory is worth monitoring, and comparing its 10-K Annual Reports from year to year can provide valuable insights.
Liquidation and Company Status

MedCath Corp. has been working towards dissolving the company and distributing its assets to shareholders.
The plan to dissolve the company was approved by shareholders, clearing the way for MedCath to sell its remaining assets.
MedCath will distribute $6.85 per share to stockholders on October 6, 2011, as a cash distribution.
The company's board of directors approved this cash distribution as part of the dissolution plan.
If this caught your attention, see: Cover Corp Shareholders
Industry and Market
MedCath Corp. operates in the healthcare industry, specifically in the field of cardiovascular services.
The company provides cardiac catheterization and electrophysiology services through its network of facilities.
MedCath Corp. has a presence in the southeastern United States, with facilities located in North Carolina and South Carolina.
Suggestion: Storage Facilities in Usa
Partnership with Montana Hospital
We've recently partnered with a Montana hospital to provide our services to patients in need. This partnership allows us to reach a wider audience and make a more significant impact in the community.
The hospital's commitment to quality care aligns with our own values, making this collaboration a natural fit. This partnership has been a game-changer for us, enabling us to offer our expertise to patients who may not have had access to it otherwise.
The hospital's state-of-the-art facilities and advanced technology have been a valuable asset in our work together. We've been able to utilize their resources to provide more comprehensive care to our patients.
Our team has been working closely with the hospital's staff to develop customized treatment plans that cater to individual patient needs. This collaboration has resulted in improved patient outcomes and increased satisfaction.
Through this partnership, we've been able to expand our services to include more specialized care, such as mental health and rehabilitation services.
Curious to learn more? Check out: Patient Capital
Ailing Hospitals in Arkansas and New Mexico
Ailing hospital operator MedCath has sold its hospitals in Arkansas and New Mexico for $192 million. This sale is part of MedCath's plan to wind down operations.
MedCath has announced the sale of its ownership in Arkansas Heart Hospital and Heart Hospital of New Mexico. These hospitals are located in Charlotte, North Carolina-based MedCath's portfolio.
The sale of these hospitals follows a pattern of hospital sales by MedCath. Just last week, MedCath sold its stake in cardiac catheterization laboratory assets in North Carolina.
MedCath is a struggling hospital operator that has been selling off its assets to stay afloat. Its sale of hospitals in Arkansas and New Mexico is a significant step in its plan to wind down operations.
The sale of these hospitals will likely have a significant impact on the local healthcare systems in Arkansas and New Mexico.
Readers also liked: Bank of the Ozarks Arena Hot Springs Arkansas
Financial Analysis
MedCath Corp's financial trajectory can be evaluated by comparing its 10-K Annual Report to its predecessor.
To see what changes occurred, you can view the differences made from one year to another in the report. This will show you what text and tables were removed, added, and changed by MedCath Corp.
By analyzing these changes, you can gain a better understanding of the company's financial progress and make more informed decisions.
Explore further: Cover Corp Report
Price Transparency in PBMs
Price Transparency in PBMs is crucial for streamlining healthcare workflows, and it starts with improving benefit verification.
Smart integrations can help with this, making it easier for patients to understand their coverage and costs.
Prior authorizations are another area where smart integrations can make a big difference, reducing administrative burdens and improving patient outcomes.
Improving patient affordability is also key, and real-time eligibility checks can help with this by ensuring patients only receive care they can afford.
Material Documents
When digging into a company's financials, it's essential to understand the material documents they provide. Medcath Corp, for instance, has made additional information available to the public through their SEC Filing as exhibits.
These exhibits can include a wide range of documents, such as material contracts and statements. You can find this information by checking the company's SEC Filing.
To get a better understanding of how Medcath Corp's management team is paid, take a look at their Annual Proxy. This document provides valuable insights into their compensation and perks.
Here are some specific details you can find in the Annual Proxy:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
By examining these documents, you can gain a more comprehensive understanding of a company's financials and management structure.
How Institutional Managers Trade Stocks
Institutional managers, such as hedge funds and pension funds, trade stocks in a way that's often different from individual investors.
They can increase or decrease their positions in a particular stock, which can significantly impact its price.

You can view which institutional managers have made changes to their stock holdings, including their ownership percentage.
Their buying and selling activity can be compared to see if they're net buyers or sellers of a stock.
The put-call ratio is another metric that can be analyzed to gauge institutional managers' sentiment towards a stock.
This ratio compares the number of put options (which give the holder the right to sell a stock at a certain price) to the number of call options (which give the holder the right to buy a stock at a certain price).
Explore further: Retail vs Institutional Investors
Compare Annual Financial Changes
To evaluate a company's financial trajectory, it's essential to view the differences made from one year to another. This can be done by comparing the current 10-K Annual Report to its predecessor.
You can read the highlights of the report to see what text and tables were removed, added, and changed by the company. This will give you a clear picture of the changes that have taken place over time.
Comparing annual financial changes can help you identify trends and patterns in the company's financial performance.
Featured Images: pexels.com


